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Identity 
Note: Rhabdomyosarcoma (RMS) are mesenchymal 
tumours belonging to the group of small round-cell 
tumors, displaying various degrees of striated muscular 
differentiation. 
 
t(2;13)(q35;q14) G-banding (above) - Courtesy G. Reza Hafez, 
Eric B.Johnson, and Sara Morrison-Delap, - Cytogenetics at 
the Waisman Center ; R-banding (below) - Courtesy Jean-Luc 
Lai. 
Classification 
Rhabdomyosarcoma covers two distinct entities: 
- Embryonal rhabdosarcoma (E-RMS) 
- Alveolar rhabdomyosarcoma (A-RMS) 





The most common pediatric soft tissue sarcoma (5 to 
8% of all malignancies in childhood): annual incidence 
is 4/106; E-RMS accounts for 75% of all RMS, and is 
observed in young children (3-12 yrs); A-RMS is found 
in the remaining 25%, and is observed in older children 
and young adults (6-21 yrs). 
Clinics 
E-RMS occurs predominantly in the head and neck 
region, the genito-urinary tract, and the 
retroperitoneum; A-RMS occurs predominantly in the 
extremities and the trunk; RMS often present as a 
tumour mass, or may be discovered from symptoms 
according. 
Pathology 
In E-RMS, tumor cells are round or spindle-shaped and 
may exhibit various degrees of muscular 
differentiation; they are often dispersed in an abundant 
myxoid stroma; the botryoid type, observed in tumors 
developped in mucosa-lined organs (vagina, bladder), 
exhibits a polypoid grape-like pattern. 
In A-RMS, tumor cells are round and more dense than 
in E-RMS and, typically, they are arranged according a 
pattern reminiscent of lung alveoli. 
Prognosis 
Dependent on the extent of disease at time of diagnosis, 
and on the type of RMS; patients with A-RMS have a 
poorer survival than those with E-RMS. 
Genetics 
Note: E-RMS and A-RMS are two distinct entities also 
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Cytogenetics 
Morphological cytogenetics 
E-RMS do not show recurrent structural chromosome 
rearrangement; the majority of the tumors are 
hyperdiploid, with an increased copy number for 
chromosomes 2, 7, 8, 12, and 13, in particular; 
comparative genomic hybridization (CGH) confirms 
these findings, showing gains of a variety of whole 
chromosomes, 2, 13, 12, 8, and 7 (in 50-60% of the 
cases), 17, 18, and 19 (40%), and the loss of 
chromosomes 16 and 10 (in 30-40%), and 15 and 14 
(20%); polymorphism studies shows that E-RMS is 
associated with the loss of heterozygosity at 11p13. 
A-RMS is characterized by two pathognomonic 
translocations: t(2;13)(q35;q14) and t(1;13)(p36;q14), 
found in 80 and 15% of the cases respectively, leading 
to the formation of gene fusions, namely PAX3-FKHR, 
in the t(2;13), and PAX7-FKHR in the t(1;13), 
generating fusion transcripts; double-minute 
chromosomes have been reported in some RMS, and 
CGH has showed a high frequency of genomic 
amplifications; the amplicons are located in 12q13-15 
(50% of the cases), 2p24 (36%), 13q14, 13q32, and 
1q36 (14%), 1q21 and 8q13-q21 (7%); the 12q13-15 
amplicon could involve genes: CHOP, MDM2, and 
SAS; MYCN gene is amplified in cases with the 
amplicon at 2p24, but unlike in neuroblastoma, no 
correlation with prognosis seems to exist in RMS; cases 
with the fusion PAX7-FKHR often show an 
amplification of the fusion gene (and more frequently 
than cases with the PAX3-FKHR gene do). 
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